Filters
Study Phase
Recruitment Status
Study Type
Eligibility Sex
Healthy Volunteers
Sort by:
Need a comprehensive medical report on "RNA"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
Studying Lymph Nodes in Patients With Stage II Colon Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Genetic: RNA marker analysis of lymph node and primary tumorsGenetic: microarray profiling of primary tumorsGenetic: reverse transcriptase-polymerase chain reaction of lymph node specimensOther: diagnostic laboratory RNA and DNA biomarker analysis of primary tumorsProcedure: regional lymph node dissectionOther: lymph node staining for H&E and pancytokeratin IHC
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 26
- Registration Number
- NCT00949312
- Locations
- 🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States
🇺🇸Walter Reed Army Medical Center, Washington, District of Columbia, United States
Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue
Completed
- Conditions
- Barrett's EsophagusEsophageal Adenocarcinoma
- First Posted Date
- 2009-05-28
- Last Posted Date
- 2015-02-12
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT00909350
- Locations
- 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030
Completed
- Conditions
- Lung Cancer
- Interventions
- Genetic: DNA analysisGenetic: RNA analysisGenetic: microarray analysisGenetic: mutation analysisGenetic: polymorphism analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 70
- Registration Number
- NCT00899535
Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer
Completed
- Conditions
- Lung Cancer
- Interventions
- Genetic: DNA/RNA sequencing and expression levelsGenetic: Protein expression analysisProcedure: Lung tumor biopsyProcedure: Blood sample
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2017-07-19
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 204
- Registration Number
- NCT00897650
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
Phase 2
Completed
- Conditions
- Hepatitis C
- Interventions
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 15
- Registration Number
- NCT00892697
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 1
Active, not recruiting
- Conditions
- Colorectal Cancer
- Interventions
- Drug: FOLFOX regimenGenetic: RNA analysisGenetic: gene expression analysisGenetic: polymerase chain reactionGenetic: western blottingOther: immunohistochemistry staining methodOther: laboratory biomarker analysisOther: pharmacological studyProcedure: positron emission tomography (PET)
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT00873275
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene
Terminated
- Conditions
- Postmenopause
- Interventions
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2010-09-06
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 185
- Registration Number
- NCT00847821
- Locations
- 🇺🇸
Pfizer Investigational Site, Norfolk, Virginia, United States
Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)
Phase 1
Completed
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2009-01-23
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 12
- Registration Number
- NCT00828269
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Phase 2
Completed
- Conditions
- Skin MetastasesRecurrent Breast CancerMale Breast CancerStage IV Breast Cancer
- Interventions
- Other: laboratory biomarker analysisGenetic: RNA analysisOther: immunoenzyme technique
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2018-01-02
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 15
- Registration Number
- NCT00821964
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
Terminated
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2021-02-12
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 29
- Registration Number
- NCT00781469
- Locations
- 🇬🇧
Kennedy Institute Clinical Trials Unit, 4 West, Charing Cross Hospital, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath